Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer

By Soetekouw Patricia   Timmer-Bonte Johanna   Drift Miep   Leeuwen Frank   Wagenaar Michiel   Die Lya   Bussink Jan   Tjan-Heijnen Vivianne  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 988-996

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

By Ono Yasushi   Hino Mitsunori   Ueda Yuka   Kamizuru Ryoko   Omata Masatoshi   Uehara Takashi   Tanaka Yosuke   Soma Tomoyuki   Kudoh Shoji  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 402-406

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer

By Maestu I.   Gomez-Aldaravi L.   Torregrosa M.D.   Camps C.   Llorca C.   Bosch C.   Gomez J.   Giner V.   Oltra A.   Albert A.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 345-354

Elsevier

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

By Helsing M.   Bergman B.   Thaning L.   Hero U.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1036-1044

Elsevier

Access to resources Recommend Favorite